Effect of 22-oxa-1,25-dihydroxyvitamin D3 on human thyroid cancer cell growth

Endocrine Journal

Volumn 46, Issue 2, 1999, Pages 243-252

  Okano, Kunihiko ^a   Usa, Toshiro ^a   Ohtsuru, Akira ^a   Tsukazaki, Tomoo ^a   Miyazaki, Youichi ^a   Yonekura, Akihiko ^a   Namba, Hiroyuki ^a   Shindoh, Hiroyuki ^a   Yamashita, Shunichi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

22 oxa 1,25 dihydroxyvitamin D3(OCT); C myc gene; Hormone therapy; Thyroid cancer cell; Vitamin D3

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; CHLORAMPHENICOL ACETYLTRANSFERASE; DNA; MESSENGER RNA; MYC PROTEIN; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CANCER INHIBITION; CELL COUNT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DNA TRANSFECTION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG RECEPTOR BINDING; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; HYBRID GENE; HYPERCALCEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; THYROID PAPILLARY CARCINOMA; TREATMENT FAILURE;

EID: 0033034543     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.46.243     Document Type: Article

References (34)

1. Haussler MR, McCain TA (1977) Basic and clinical concepts related to vitamin D metabolism and action. New Engl J Med 297: 1041-1050.
2. Norman AW, Roth J, Orci L (1982) The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev 3: 331-366.
3. DeLuca HF, Schnoes HK(1983) Vitamin D: Recent advances. Annu Rev Biochem 52: 411-439.
4. Reichel H, Koeffler HP, Norman AW (1989) The role of the vitamin D endocrine system in health and disease. New Engl J Med 320: 980-991.
5. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM. Wiernik, P. H. (1997) All-trans-retinoic acid in acute promyelocytic leukemia. New England Journal of Medicine 337: 1021-1028.
6. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon CC, Grosveld F, Pandolfi PP (1998) Role of PML in cell growth and the retinoic acid pathway. Science 279: 1547-1551.
7. 3 and malignant malanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108: 1083-1086.
8. Zhao X, Feldman D (1993) Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology 132: 1808-1814.
9. 3 in HL-60 promyelocytic leukemia cells. J Biol Chem 262: 4104-4108.
10. Reitsma PH, Rothberg PG, Astrin SM, Trial J, Bar SZ, Hall A, Teitelbaum SL, Kahn AJ (1983) Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature 306: 492-494.
11. Bikle DD (1992) Clinical counterpoint: vitamin D: new action, new analogs, new therapeutic potential. Endocr Rev 13: 765-784.
12. Inoue D, Matsumoto T, Ogata E, Ikeda K (1993) 22-oxacalcitriol, a noncalcemic analogue of calcitriol, supresses both cell proliferation and parathyroid hormone-related peptide gene expression in human T cell lymphotropic virus, type 1-infected T cells. J Biol Chem 268: 16730-16736.
13. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 129: 832-837.
14. Hay ID (1990) Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19: 545-576.
15. Bergenfelz A, Ahren B (1993) Calcium metabolism after hemithyroidectomy. Horm Res 39: 56-60.
16. Dulgeroff AJ, Hershman JM (1994) Medical therapy for differentiated thyroid carcinoma. Endocr Rev 15: 500-515.
17. Yamashita S, Ong J, Fagin JA, Melmed S (1986) Expression of the myc cellular proto-oncogene in human thyroid tissue. J Clin Endocrinol Metab 63: 1170-1173.
18. Kimura H, Yamashita S, Namba H, Tominaga T, Tsuruta M, Yokoyama N, Izumi M, Nagataki S (1992) Interleukin-1 inhibits human thyroid carcinoma cell growth. J Clin Endocrinol Metab 75: 596-602.
19. Usa T, Tsukazaki T, Namba H, Ohtsuru A, Kimura H, Villadolid MC, Nagataki S, Yamashita S (1994) Correlation between suppression of c-myc and antiproliferative effect of transforming growth factor-beta 1 in thyroid carcinoma cell growth. Endocrinology 135: 1378-1384.
20. 3 analogue Chem Pharm Bull 34: 4410-4413.
21. Lacey DL, Axelrod J, Chappel JC, Kahn AJ, Teitelbaum SL (1987) Vitamin D affects proliferation of a murine T helper cell clone. J Immunol 138: 1680-1686.
22. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 162: 156-159.
23. Yamashita S, Kimura H, Ashizawa K, Nagayama Y, Hirayu H, Izumi M Nagataki S (1989) Interleukin-1 inhibits thyrotrophin-induced human thyroglobulin gene expression. J Endocrinol 122: 177-183.
24. Iguchi AS, Okazaki T, Itani T, Ogata M, Sato Y, Ariga H (1988) An initiation site of DNA replication with transcriptional enhancer activity present upstream of the c-myc gene. EMBO J 7: 3135-3142.
25. Ponte P, Gunning P, Blau H, Kedes L (1983) Human actin genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta-and gamma-cytoskeletal genes: 3′ untranslated regions are isotype specific but are conserved in evolution. Mol Cell Biol 3: 1783-1791.
26. Hatano M, Nakata K, Nakao K, Tsutsumi T, Ohtsuru A, Nakamura T, Tamaoki T, Nagataki S (1992) Hepatocyte growth factor down-regulates the alpha-fetoprotein gene expression in PLC/PRF/5 human hepatoma cells. Biochem Biophys Res Commun 189: 385-391.
27. Tanaka H, Hruska KA, Seino Y, Malone D, Nishii Y, Teitelbaum, SL (1991) Disassociation of the macrophage-maturational effects of vitamin D from respiratory burst priming. J Biol Chem 266: 10888-10892.
28. 3. J Nutr Sci Vitaminol 35: 529-533.
29. 3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia. FEBS Lett 226: 58-62.
30. Ozono K, Liao J, Kerner SA, Scott RA, Pike JW (1990) The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J Biol Chem 265: 21881-21888.
31. 3 receptors: structure and function in transcription. [Review] Annu Rev Nutr 11: 189-216.
32. 3. Proc Natl Acad Sci U.S.A. 89: 8097-8101.
33. 3 analogue (KH/060) with 9-cis-retionoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res 56: 3570-3576.
34. 3 increases the sensitivity of human renal carcinoma cells to tumor necrosis factor alpha but not to interferon alpha or lymphokine-activated killer cells. J Endocrinol 149: 327-333.